Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Paolo Antonio Ascierto, Naples, Italy – FDA Inspections
Company
•Italy

Paolo Antonio Ascierto, Naples, Italy – FDA Inspections

Inspection records and compliance data for Paolo Antonio Ascierto in Naples. 1 FDA inspection on record, last inspected June 19, 2015.

Sign in to open in Dashboard
Company Profile

This profile covers Paolo Antonio Ascierto based in Naples, Italy.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected June 19, 2015.

FDA inspections (1)

DateResultFDA center(s)Insp. #
June 19, 2015NAIHuman Drugs · Bioresearch Monitoring931280
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Marilena Cesari, M.D.
ACS Dobfar s.p.a.
B. Kolormakeup & Skincare SpA Societa Benefit
Giuseppe Plazzi, M.D.
Industriale Chimica S.r.l.
Andrea Maria D'Armini
Advanced Accelerator Applications (Italy) SRL
Guido Fanelli, M.D.
Giulia V. Bianchi, M.D.
Fotios Loupakis, M.D., Ph.D
Company Information

Name

Paolo Antonio Ascierto

FEI Number

3011461333

Address

Via Mariano Semmola, Naples, Italy

Country

Italy

ID: c771f458-4827-4f3e-8ea7-f280d81aaac6

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.